You just read:

Angionetics & A Huapont Life Sciences Affiliate Enter Agreement To Commercialize Generx® Angiogenic Gene Therapy Product Candidate For Ischemic Heart Disease In China

News provided by

Taxus Cardium (CRXM)

11 Jul, 2016, 09:05 ET